This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fagher, B. Articles by Larsson, H. Search for Related Content PubMed PubMed Citation Articles by Fagher, B. Articles by Larsson, H. Social Bookmarking                         What's this?

Blood Viscosity During Long-Term Treatment with Ticlopidine in Patients with Intermittent Claudication. A Double-Blind Study

Angiology Section, Department of Internal Medicine, University Hospital of Lund

Sylvi Persson

Research Department, University Hospital of Lund, Lund, Sweden

Gunnar Persson

Angiology Section, Department of Internal Medicine, University Hospital of Lund

Hans Larsson

Angiology Section, Department of Internal Medicine, University Hospital of Lund

The aim was to test within a randomized, double-blind trial whether the antiaggregant drug ticlopidine might reduce blood viscosity as has been claimed. Sixteen patients with intermittent claudication were studied before and after three years of treatment with ticlopidine, 500 mg/day, or placebo. At base line, the viscosity values were significantly higher as compared with a reference group of healthy subjects. Whole-blood viscosity, measured at four different shear rates at hematocrit adjusted to a standard 40%, decreased significantly at follow-up, with no difference between ticlopidine treatment and placebo. Hema tocrit showed a slight increase in the placebo group. The viscosity parameters were unrelated to lower limb blood flow variables, ankle/brachial index, and walking distances. The mechanism behind the overall decrease in whole-blood viscosity is obscure but could possibly be explained by lifestyle changes. Smok ing habits were, however, unaltered. Since plasma viscosity remained increased, it might indicate that some erythrocyte factor, notably red cell aggregability and deformability, had improved. It is concluded that ticlopidine had no long-term effect on blood viscosity.

Angiology, Vol. 44, No. 4, 300-306 (1993)
DOI: 10.1177/000331979304400406


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?